hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06358274, orgStudyIdInfo id: MED-2024-32848, briefTitle: Nutritional and Metabolic Dynamics of Thru-Hiking: A Longitudinal Study on the Colorado Trail, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-07-01, completionDateStruct date: 2024-07-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: University of Minnesota, class: OTHER, descriptionModule briefSummary: Thru-hiking the Colorado Trail presents distinct challenges owing to its diverse landscapes and high altitudes. The study aims to delve into the physiological and nutritional facets of extended wilderness trekking among thru-hikers. Activities encompass participant recruitment from the Colorado Trail Foundation community, baseline and post-trail assessments including blood lipid panel analysis and anthropometric measurements, data collection during the trail period involving recording daily mileage, exertion levels, and dietary intake, rigorous statistical analysis to explore correlations among various parameters, and adherence to ethical considerations including obtaining formal approval and ensuring informed consent procedures are followed to safeguard participants' rights and privacy. Through this endeavor, the study seeks to offer insights into the metabolic responses and cardiovascular implications associated with thru-hiking, shedding light on the interplay between diet, lifestyle factors, and metabolic health in challenging environments.The specific aims include examining the metabolic responses and cardiovascular implications associated with thru-hiking, exploring correlations between dietary intake and blood lipid profiles, and elucidating the interplay between lifestyle factors and metabolic health in demanding environments. This study is not limited to program evaluation, quality assurance, or improvement activities within a specific department or setting but rather seeks to contribute to scientific knowledge and inform evidence-based recommendations for individuals engaging in thru-hiking or similar high-intensity activities., conditionsModule conditions: Thru-hiking, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Thru-hiking, outcomesModule primaryOutcomes measure: blood lipid panel: total cholesterol, primaryOutcomes measure: blood lipid panel: high-density lipoprotein (HDL), primaryOutcomes measure: blood lipid panel: low-density lipoprotein (LDL), primaryOutcomes measure: blood lipid panel: triglycerides, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06358261, orgStudyIdInfo id: IRB00433279, secondaryIdInfos id: R03DK135898, type: NIH, link: https://reporter.nih.gov/quickSearch/R03DK135898, briefTitle: Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2025-09, completionDateStruct date: 2025-09, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-23, sponsorCollaboratorsModule leadSponsor name: Johns Hopkins University, class: OTHER, collaborators name: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), descriptionModule briefSummary: The investigators overarching goal is to increase the percentage of patients engaging in diabetes prevention activities to reduce the incidence of diabetes. The investigators objective is to design and pilot test a prediabetes clinical decision support (CDS) tool in the electronic health record (EHR) that will assess the patient's activation level based on responses to a questionnaire. Based on the patient's assessed level of activation, the tool will generate several communication recommendations to guide clinicians in conversations related to prediabetes/lifestyle change and tailor recommendations about available resources (e.g., care manager, health coach, DPP) to support patient activation., conditionsModule conditions: PreDiabetes, conditions: Lifestyle, Healthy, conditions: Activation, Patient, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: pilot group-randomized controlled trial, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Diabetes Prevention Patient Activation Clinical Decision Support Tool, outcomesModule primaryOutcomes measure: patient activation as assessed by the Patient Activation Measure Survey (PAM), secondaryOutcomes measure: number of participants referred to Diabetes Prevention Program, secondaryOutcomes measure: number of participants prescribed metformin, secondaryOutcomes measure: percent of participants who make diet changes, secondaryOutcomes measure: change in amount and frequency of physical activity, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06358248, orgStudyIdInfo id: SPHERE, briefTitle: Standardized Physician-modified Fenestrated Endograft Registry, acronym: SPHERE, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-01, primaryCompletionDateStruct date: 2028-10-01, completionDateStruct date: 2033-10-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: University Hospital Padova, class: OTHER, descriptionModule briefSummary: Multicenter retrospective study including all consecutive patients treated by PMEG using a standard modification technique of Valiant Captivia (Medtronic, Minneapolis, MN-USA)., conditionsModule conditions: Aortic Aneurysm, Thoracoabdominal, conditions: Aortic Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Physician-modification of Valiant Captivia Endograft (Medtronic, Minneapolis, MN-USA)., outcomesModule primaryOutcomes measure: Technical success, primaryOutcomes measure: Freedom from target vessel instability, primaryOutcomes measure: Freedom from endograft instability, secondaryOutcomes measure: Early (30-days) Major Adverse Event (MAE), secondaryOutcomes measure: Aneurysm sac dynamics, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Vascular and Endovascular Clinic - Padova University, status: RECRUITING, city: Padova, zip: 35020, country: Italy, contacts name: Michele Piazza, Pr, role: CONTACT, phone: 3498644688, email: michele.piazza@unipd.it, geoPoint lat: 45.40797, lon: 11.88586, hasResults: False
protocolSection identificationModule nctId: NCT06358235, orgStudyIdInfo id: SDU-IH-HA-01, briefTitle: The Effect of Music Therapy on Dyspnea Severity and Vital Signs, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-07, primaryCompletionDateStruct date: 2024-05-30, completionDateStruct date: 2024-06-30, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Suleyman Demirel University, class: OTHER, descriptionModule briefSummary: This study aims to investigate the effect of music therapy on dyspnea severity and quality of life indicators in patients with Chronic Obstructive Pulmonary Disease (COPD) admitted to the intensive care unit. The study will be conducted at Isparta City Hospital and Kumluca State Hospital in Antalya, Turkey, using an experimental design. Patients will be divided into experimental and control groups, selected using randomization.Patients in the experimental group will receive music therapy in the Hüseyni maqam, while those in the control group will not receive any music therapy. Life indicators and Modified Borg Scale (MBS) values of patients in the experimental group will be recorded before, immediately after, and 30 minutes post-application. Music therapy will be administered to patients for only one day, once in the morning. Data for patients in the control group will be collected at the same time intervals. The results of this study aim to contribute to the literature on the impact of music therapy on dyspnea severity and quality of life indicators in COPD patients., conditionsModule conditions: Dyspnea, conditions: Chronic Obstructive Pulmonary Disease, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Music Therapy, interventions name: No Music therapy, outcomesModule primaryOutcomes measure: Patient Identification Form, primaryOutcomes measure: Modified Borg Scale, primaryOutcomes measure: Vital Signs Record Chart, primaryOutcomes measure: Blood Test Results Record Chart, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Suleyman Demırel University, status: RECRUITING, city: Isparta, zip: 32200, country: Turkey, contacts name: Hafize Aydemir, role: CONTACT, phone: +905078380979, email: aydemirhafize1998@gmail.com, geoPoint lat: 37.76444, lon: 30.55222, hasResults: False
protocolSection identificationModule nctId: NCT06358222, orgStudyIdInfo id: LUNon-invasive, briefTitle: Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-12-15, primaryCompletionDateStruct date: 2027-12-31, completionDateStruct date: 2027-12-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Shanghai Chest Hospital, class: OTHER, descriptionModule briefSummary: This is a single center, prospective and observational study conducted in three stages to predict the NSCLC lymph node metastasis based on ctDNA/specific methylation molecular features combined with PET-CT imaging features and intervention study., conditionsModule conditions: Carcinoma, conditions: Non-small Cell Lung Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Blood ctDNA + methylation + PET-CT and Postoperative pathology, interventions name: MRD+ methylation (or combined with PET-CT) and Invasive mediastinoscopy /EBUS-TBNA, interventions name: Intraoperative lymph node dissection, outcomesModule primaryOutcomes measure: Negative prediction value (NPV) of lymph node metastasis rates, primaryOutcomes measure: Disease-free survival (DFS), primaryOutcomes measure: ctDNA-free interval (CFI), secondaryOutcomes measure: Overall Survival (OS), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Shanghai Chest Hospital, status: RECRUITING, city: ShangHai, country: China, contacts name: Feng Yao, PhD, role: CONTACT, phone: 021-22200000, email: yaofeng@shsmu.edu.cn, geoPoint lat: 31.22222, lon: 121.45806, hasResults: False
protocolSection identificationModule nctId: NCT06358183, orgStudyIdInfo id: ESC001, briefTitle: Surgical Capacity in Zimbabwean Public Hospitals, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-04-24, primaryCompletionDateStruct date: 2024-02-25, completionDateStruct date: 2024-03-15, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Parirenyatwa Hospital, class: OTHER, descriptionModule briefSummary: This study aimed to understand how ready Zimbabwe's public hospitals are to perform essential surgeries, which are critical for treating a wide range of health issues from emergencies like car accidents to planned procedures such as childbirth by caesarean section. The researchers looked at hospitals across Zimbabwe to see what kind of surgery facilities, equipment, and specialists were available., conditionsModule conditions: Surgery, conditions: Anesthesia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 80, type: ACTUAL, armsInterventionsModule interventions name: No intervention, outcomesModule primaryOutcomes measure: Bellwether procedures, primaryOutcomes measure: Procedures, primaryOutcomes measure: SAO density, primaryOutcomes measure: Infrastructure, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Parirenyatwa Hospital, city: Harare, country: Zimbabwe, geoPoint lat: -17.82772, lon: 31.05337, hasResults: False
protocolSection identificationModule nctId: NCT06358157, orgStudyIdInfo id: CLN02001, briefTitle: The Ladera Large Bore Closure Feasibility Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2025-02, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Ladera Medical, class: INDUSTRY, collaborators name: Avania, descriptionModule briefSummary: This study evaluates the safety and performance of the Ladera Medical suture-mediated large bore closure (LBC) system in gaining post procedure hemostasis in subjects undergoing interventional catheterization procedures using a large-bore procedure sheath., conditionsModule conditions: Vascular Closure, conditions: Femoral Arteriotomy Closure, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Prospective, non-randomized, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Ladera LBC System, outcomesModule primaryOutcomes measure: Primary Safety Endpoint: Major Arterial Access Site Closure-related Complications, primaryOutcomes measure: Primary Performance Endpoint: Time to Hemostasis, secondaryOutcomes measure: Secondary Safety Endpoint: Minor Arterial Access Site Closure-related Complications, secondaryOutcomes measure: Secondary Performance Endpoint: Time-to-Ambulation, secondaryOutcomes measure: Secondary Performance Endpoint: Time-to-Discharge Eligibility, secondaryOutcomes measure: Secondary Performance Endpoint: Incidence of Procedural Success, secondaryOutcomes measure: Secondary Performance Endpoint: Incidence of Device Technical Success, eligibilityModule sex: ALL, minimumAge: 21 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06358144, orgStudyIdInfo id: IRB00111438, secondaryIdInfos id: R01DA053209, type: NIH, link: https://reporter.nih.gov/quickSearch/R01DA053209, briefTitle: Cannabis Edibles Packaging Imagery Experiment, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-07, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Wake Forest University Health Sciences, class: OTHER, collaborators name: National Institute on Drug Abuse (NIDA), descriptionModule briefSummary: The purpose of this study is to assess differences in perceptions of product appeal, harm, and subsequent willingness to try cannabis edibles products with/without packaging imagery., conditionsModule conditions: Cannabis Use, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants will complete a 15-minute online survey, where they will be randomized to one of five conditions: four intervention conditions with a different image on the package and one without any imagery., primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 1250, type: ESTIMATED, armsInterventionsModule interventions name: Packaging imagery, interventions name: No Imagery (Control), outcomesModule primaryOutcomes measure: Product Appeal Scoring, primaryOutcomes measure: Harm Perceptions (Absolute) Scoring, primaryOutcomes measure: Willingness to Try Product Scoring, secondaryOutcomes measure: Appeal to Children Scoring, secondaryOutcomes measure: Harm Perceptions (Relative) Scoring, secondaryOutcomes measure: Perception of Quality Scoring, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Wake Forest University Health Sciences, city: Winston-Salem, state: North Carolina, zip: 27157, country: United States, contacts name: Alexandra Zizzi, MSPH, role: CONTACT, geoPoint lat: 36.09986, lon: -80.24422, hasResults: False
protocolSection identificationModule nctId: NCT06358131, orgStudyIdInfo id: R.21.10.1493, briefTitle: Propofol Versus Midazolam in Sedation for Upper and Lower Gastrointestinal Endoscopy., statusModule overallStatus: RECRUITING, startDateStruct date: 2022-01-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2024-08-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: There has been rapid growth in the number and complexity of gastrointestinal (GI) endoscopic procedures performed during the last decade. To ensure safe and effective upper GI endoscopy, the choice of an appropriate sedative agent is crucial. Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal \[GI\] endoscopy usually performed under moderate sedation Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal \[GI\] endoscopy usually performed under moderate sedation. Benzodiazepines still the most common sedative agents used for conscious sedation, either solely or in combination with opioids for upper GI endoscopy. Propofol is a hypnotic drug used for induction of anesthesia with short half-life that permits rapid patient recovery and discharge. Thus, its use is for upper GI endoscopy was adopted in many endoscopy centers. So we are going to Evaluate all adverse events related to anesthesia; in patients recruited for upper and lower endoscopy and compare between propofol and midazolam based anesthesia associated adverse events.Also we are going to Evaluate patient and endoscopist satisfaction as regarding propofol and midazolam anesthesia., conditionsModule conditions: Gastrointestinal Diseases, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 656, type: ESTIMATED, armsInterventionsModule interventions name: Endoscopy, outcomesModule primaryOutcomes measure: Evaluate all adverse events related to anesthesia; in patients recruited for upper and lower endoscopy and compare between propofol and midazolam based anesthesia associated adverse events., secondaryOutcomes measure: Evaluate patient and endoscopist satisfaction as regarding propofol and midazolam anesthesia., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Mansoura University, status: RECRUITING, city: Mansoura, state: Dakhlia, zip: 35516, country: Egypt, contacts name: Asmaa Gameel, MD, role: CONTACT, phone: 01025835429, email: asmaagameel@mans.edu.eg, geoPoint lat: 31.03637, lon: 31.38069, locations facility: MansouraU, status: RECRUITING, city: Mansoura, country: Egypt, contacts name: Asmaa Gameel, MD, role: CONTACT, phone: 201025835429, email: asmaagameel165@gmail.com, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False
protocolSection identificationModule nctId: NCT06358105, orgStudyIdInfo id: id. 6457, briefTitle: Simulator Training to Improve Interventional Cardiologist Skills (STARTERS) Trial, acronym: STARTERS, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-11-15, primaryCompletionDateStruct date: 2024-11-15, completionDateStruct date: 2025-11-15, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to learn if simulator-based training will improve interventional cardiology fellows' skills and will improve patient outcomes.The main questions it aims to answer are:* Does this training improve specific operative parameters recorded during initial coronary interventions performed as first operators under senior supervision?* Will major and minor procedural complications be reduced after simulator-based training?Interventional cardiology fellows in their first year of training will be randomized between standard master-apprentice training or simulator-based training before starting their cath lab period.They will be supervised during their cath lab period as first operators by senior interventional cardiologists.During their first 50 procedures performed as supervised first operator, specific procedural data will be collected., conditionsModule conditions: Coronary Artery Disease, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 400, type: ESTIMATED, armsInterventionsModule interventions name: Simulator-based training, interventions name: Standard training, outcomesModule primaryOutcomes measure: Mean total fluoroscopy radiation time (expressed in seconds), secondaryOutcomes measure: Mean arterial cannulation time (expressed in seconds), secondaryOutcomes measure: Total radiation dose (expressed in cGy*cm2), secondaryOutcomes measure: Total contrast dose (expressed in ml), secondaryOutcomes measure: Failure to achieve arterial cannulation (e.g.: rate of failure for each partecipant), secondaryOutcomes measure: Failure to achieve right coronary cannulation (e.g.: rate of failure for each partecipant), secondaryOutcomes measure: Failure to achieve left coronary cannulation (e.g.: rate of failure for each partecipant), secondaryOutcomes measure: Number of catheters used, secondaryOutcomes measure: Any major or minor procedural and clinical complication, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione Policlinico Univrsitario Agostino Gemelli IRCCS, city: Rome, zip: 00168, country: Italy, geoPoint lat: 41.89193, lon: 12.51133, hasResults: False